About STATinMED Research
STATinMED Research is a Healthcare company based in Ann Arbor (United States) founded in 2007, and was acquired by Ancor Capital Partners in September 2018. It operates as a healthcare data analytics services provider. STATinMED Research offers products and services including Data Services and Consulting Services. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its legal entity is STATinMED, LLC. Its competitors include OPEN Health, Target RWE, Secura Bio, Abacus Medicine and Hylant and 2 more; 3 of its 7 listed competitors have raised funding.
Company details
STATinMED Research was founded in 2007 and is headquartered in Ann Arbor, United States. Healthcare data analytics services are offered to the pharmaceutical and biotechnology industries. Key services include outcomes research, literature reviews, meta-analyses, data visualization, and medical writing. Operations focus on supporting evidence-based decision-making through analytical and research methodologies in the healthcare sector.
- Headquarters Ann Arbor, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website statinmed.com
- Social LinkedIn X YouTube
- Acquired by Ancor Capital Partners (Sep 2018)
- Legal Name Statinmed, Llc.
- InvestorsCapital Southwest
& 4 more
- Acquired byAncor Capital Partners
(Sep 2018)
Products & Services of STATinMED Research
STATinMED Research offers a comprehensive portfolio of products and services, including Data Services and Consulting Services.
Delivers in-house and commercial data for healthcare needs and insights.
Provides customized solutions for real-world evidence and decision support.
Apps and channels of STATinMED Research
its YouTube channel STATinMED has 12 subscribers and 3 videos.
Videos from STATinMED Research
The most watched videos on STATinMED Research's YouTube channel, STATinMED (12 subscribers). Click a video to play it here.
More on STATinMED.
Funding Insights of STATinMED Research
- Total Rounds 1
- Investors Count 4
All 1 funding rounds of STATinMED Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | – | Debt – Conventional | – | – |
5 investors in total: 5 institutional.
Investors in STATinMED Research
STATinMED Research has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Capital Southwest, Harbert Management and Dos Rios Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm based out of USA | – | dosriospartners.com | Dallas, United States | |
Infrastructure, hedge, private equity, and debt fund focused on multiple sectors | 1993 | harbert.net | Birmingham, United States | |
Private equity investment firm | 1961 | capitalsouthwest.com | Dallas, United States | |
Ancor Capital Partners is engaged in private equity investments. | 1994 | ancorcapital.com | Southlake, United States | |
Offers alternative investment funds and strategies for everyday investors and professionals. | 1985 | cioninvestments.com | New York, United States |
Investor details for STATinMED Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of STATinMED Research
8 people are tracked at STATinMED Research (5 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Deborah Freedman | Executive Vice President Corporate Development, Heor/rwe Solutions | Leadership |
Jason Drenning | President | Leadership |
Felicia Summerville | Head Of Human Resources, Director | Leadership |
Maxine Fisher | Vice President, RWE | Leadership |
Mike Rials | Vice President Strategic Initiatives | Leadership |
Huiqi Wang | Statistical Programmer | Team |
Celina H. | Senior Project Manager | Team |
Yazid Barhoush | Biostatistician | Team |
Complete people profiles for STATinMED Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of STATinMED Research
3 dated milestones of STATinMED Research across 11 years, from founding to its latest funding, stage changes and deals.
- Founded STATinMED Research is founded.
- Funding First funding round.
- Exit Acquired by Ancor Capital Partners.
Competitors of STATinMED Research
STATinMED Research has 7 listed competitors in our database, 3 of them funded. They include OPEN Health, Target RWE, Secura Bio, Abacus Medicine and Hylant, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| openhealthgroup.com | 2016 | Marlow, United Kingdom | $5.28M | 297 | Provider of healthcare marketing services | |
| targetrwe.com | 2017 | Durham, United States | – | 116 | Marketing services to the pharmaceutical industry are provided. | |
| securabio.com | 2018 | Henderson, United States | $55M | – | Consulting services for market access and health outcomes are provided. | |
| abacusmedicine.com | 2004 | Copenhagen, Denmark | $57.64M | 1,052 | Consulting services for market access, health economics and outcomes research | |
| hylant.com | 1935 | Toledo, United States | – | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. | |
| vitaccess.com | 2002 | Oxford, United Kingdom | – | 40 | Provider of market access & HEOR consulting services for pharmaceutical industries | |
| gba-group.com | 1975 | Hamburg, Germany | – | – | GBA Group is recognized as a leading life sciences service provider. |
Detailed competitors of STATinMED Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of STATinMED Research
The website of STATinMED Research (statinmed.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 123.3% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as STATinMED Research (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Statinmed Research
Complete news archive for STATinMED Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about STATinMED Research
STATinMED Research was founded in 2007 and raised its 1st funding round 11 years after it was founded.
STATinMED Research is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
STATinMED Research was founded in 2007 and is headquartered in Ann Arbor, United States. Healthcare data analytics services are offered to the pharmaceutical and biotechnology industries. Key services include outcomes research, literature reviews, meta-analyses, data visualization, and medical writing. Operations focus on supporting evidence-based decision-making through analytical and research methodologies in the healthcare sector.
STATinMED Research's top competitors include OPEN Health, Abacus Medicine and Target RWE.
STATinMED Research offers Data Services and Consulting Services.
STATinMED Research has 5 investors. Key investors include Capital Southwest, Harbert Management, Dos Rios Partners, CION Investments, and Ancor Capital Partners.
STATinMED Research operates through Statinmed, Llc..
Yes. STATinMED Research was acquired by Ancor Capital Partners in September 2018.